LGALS3 and thyroid gland carcinoma: Besides, Galectin-3 expression in thyroid carcinoma has been linked with aggressive clinical features whilst negative Galectin-3 carcinomas seem to present a slightly more favorable course with fewer lymph node metastases [34].